Autoimmunity and inflammation are associated with marked changes in lipid and lipoprotein
metabolism in SLE. Autoantibodies and cytokines are able to modulate lipoprotein lipase …

A growing body of evidences reinforces the close link between systemic lupus
erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk …

Objective The novel description of antibodies to lipoprotein lipase (anti‐LPL) associated with
dyslipoproteinemia prompted us to analyze the association of anti‐LPL with clinical and …

Systemic lupus erythematosus (SLE) is a heterogeneous disease which is characterized
with excessive inflammation and autoantibodies, macrophage and complement activation …

The accelerated atherosclerosis that occurs in some patients with systemic lupus
erythematosus (SLE) has a complex pathogenesis, including alterations in lipids …

Systemic lupus erythematosus is commonly associated with early onset cardiovascular
disease and is often associated with hyperlipidaemia. This review examines the evidence …

Inflammation and dysregulated cholesterol metabolism are key components in the
pathogenesis of atherosclerosis. Premature atherosclerosis is a characteristic feature of …

Cardiovascular disease is one of the major causes of morbidity and mortality in patients with
systemic lupus erythematosus (SLE). Accelerated atherosclerosis is related to traditional …

Objective: To determine the influence of systemic lupus erythematosus (SLE), disease
activity, and anticardiolipin antibodies (aCL) on lipid profile, in order to identify patients with …

Accelerated atherosclerosis is a major cause of morbidity and mortality in patients with
systemic lupus erythematosus (SLE). Certain 'classic'risk factors are associated with …